Synopsis: HSBC maintained its Buy rating on UPL with a Rs. 880 target, citing improving farmer cash flows, stronger agri-input demand, and an expected 55.34 percent upside potential.
This Agrochemical Stock, engaged in the manufacturing and marketing of crop protection products, seeds, biological solutions, and sustainable agricultural technologies across global markets, is in focus after HSBC gave a buy target of Rs. 880, which has an upside potential of 55.34 percent.
With a market capitalization of Rs. 47,822.19 crore, the shares of UPL Limited were currently trading at Rs. 566.50 per equity share, down nearly 0.84 percent from its previous day’s close price of Rs. 571.30.
Reason Behind the Surge:
HSBC, a prominent brokerage firm, has recommended a “Buy” call on UPL Limited with a target price of Rs. 880 per share, indicating an upside potential of 55.34 percent from its current price of Rs. 566.50 per share.
HSBC has maintained its Buy rating on UPL after meeting industry stakeholders in Punjab, where sentiment remained positive despite a delay in sowing. Farmers are in a stronger financial position due to better cash flows, which is expected to support spending on crop protection and other agricultural inputs.
The brokerage believes ag-input demand could grow by 5–10 percent in Q1FY27 as farmers continue investing in their crops. This healthy demand outlook, combined with improving rural conditions, is expected to support UPL’s sales growth and earnings, reinforcing HSBC’s positive view on the stock.
Business Highlights:
UPL Limited is one of the world’s leading agricultural solutions companies, with operations in more than 140 countries. It ranks 5th globally in agrochemicals and 10th in seeds, while also being a leading player in biological solutions. The company operates 43 crop protection manufacturing sites, 32 seed processing facilities, and is recognized as India’s leading specialty chemicals company.
The company places a strong focus on innovation, supported by 57 crop protection R&D centres, 39 seed R&D centres, and a portfolio of over 16,000 product registrations. UPL also holds more than 3,200 patents, with over 30 percent of its agrochemical portfolio protected by intellectual property, helping drive sustainable growth and product development.
Management Guidance:
UPL Limited has provided a positive outlook for Q1FY27, expecting revenue growth of 10-14 percent and EBITDA growth of 14-18 percent. The company plans to improve the quality of earnings by increasing contribution-led revenue, optimizing its product portfolio, and improving plant utilization while controlling costs.
The company is also focused on generating stronger cash flows by improving cash conversion and reducing debt. UPL aims to strengthen its balance sheet through continued deleveraging while maintaining a disciplined approach to capital allocation, supporting profitable and sustainable long-term growth.
Business and Products:
UPL’s business spans the agricultural value chain, with offerings that include herbicides, fungicides, insecticides, seed treatments, biological solutions, plant nutrition products, and seeds. The company promotes its OpenAg® strategy, which emphasizes collaboration across farmers, distributors, researchers, and food companies to improve agricultural productivity and sustainability. UPL also operates manufacturing and research facilities across multiple continents.
Company Overview:
UPL Limited is an Indian multinational company focused on agricultural solutions, including crop protection products, seeds, biologicals, and post-harvest technologies. Headquartered in Mumbai, it has grown into one of the world’s largest agrochemical companies, serving farmers across more than 130 countries through a broad portfolio of conventional and sustainable farming solutions.
Recent Quarter Results:
Coming into financial highlights, UPL Limited’s revenue has increased from Rs. 15,573 crore in Q4 FY25 to Rs. 18,335 crore in Q4 FY26, which has grown by 17.74 percent. The net profit has also grown by 19.93 percent from Rs. 1,079 crore in Q4 FY25 to Rs. 1,294 crore in Q4 FY26.
UPL Limited’s revenue and net profit have grown at a CAGR of 14 percent and 7 percent, respectively, over the last ten years.
In terms of return ratios, the company’s ROCE and ROE stand at 10.2 percent and 5.91 percent, respectively. UPL Limited has an earnings per share (EPS) of Rs. 22.8, and its debt-to-equity ratio is 0.68x.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
